Skip to main content
Log in

Oral direct factor Xa inhibitors carry their weight

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Mahmoudi M, et al. The Cost-Effectiveness of Oral Direct Factor Xa Inhibitors Compared with Low-Molecular-Weight Heparin for the Prevention of Venous Thromboembolism Prophylaxis in Total Hip or Knee Replacement Surgery. Pharmacotherapy : 26 Apr 2013. Available from: URL: http://dx.doi.org/10.1002/phar.1269

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oral direct factor Xa inhibitors carry their weight. PharmacoEcon Outcomes News 678, 9 (2013). https://doi.org/10.1007/s40274-013-0405-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0405-7

Navigation